Striatal μ-opioid receptor activation triggers direct-pathway GABAergic plasticity and induces negative affect

Wei Wang,Xueyi Xie,Xiaowen Zhuang,Yufei Huang,Tao Tan,Himanshu Gangal,Zhenbo Huang,William Purvines,Xuehua Wang,Alexander Stefanov,Ruifeng Chen,Lucas Rodriggs,Anita Chaiprasert,Emily Yu,Valerie Vierkant,Michelle Hook,Yun Huang,Emmanuel Darcq,Jun Wang
DOI: https://doi.org/10.1016/j.celrep.2023.112089
IF: 8.8
2023-02-01
Cell Reports
Abstract:Withdrawal from chronic opioid use often causes hypodopaminergic states and negative affect, which may drive relapse. Direct-pathway medium spiny neurons (dMSNs) in the striatal patch compartment contain μ-opioid receptors (MORs). It remains unclear how chronic opioid exposure and withdrawal impact these MOR-expressing dMSNs and their outputs. Here, we report that MOR activation acutely suppressed GABAergic striatopallidal transmission in habenula-projecting globus pallidus neurons. Notably, withdrawal from repeated morphine or fentanyl administration potentiated this GABAergic transmission. Furthermore, intravenous fentanyl self-administration enhanced GABAergic striatonigral transmission and reduced midbrain dopaminergic activity. Fentanyl-activated striatal neurons mediated contextual memory retrieval required for conditioned place preference tests. Importantly, chemogenetic inhibition of striatal MOR<sup>+</sup> neurons rescued fentanyl withdrawal-induced physical symptoms and anxiety-like behaviors. These data suggest that chronic opioid use triggers GABAergic striatopallidal and striatonigral plasticity to induce a hypodopaminergic state, which may promote negative emotions and relapse.
cell biology
What problem does this paper attempt to address?